Care Bundle for Spontaneous Intracerebral Hemorrhage

International Care Bundle Evaluation in Cerebral Hemorrhage Research

Recruiting Phase 4 Interventional Study
Intracerebral Hemorrhage Intracerebral Haemorrhage Intraventricular Hemorrhage Stroke Cerebrovascular Disease
Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 4
Study type
Interventional
Purpose
Treatment
Participants needed
3,500 (estimated)
Sponsor
Region Skane · Other
Who this trial is looking for

This trial is looking for adults who have had a spontaneous brain bleed. Participants will receive a structured treatment package to see if it helps improve their recovery over three months compared to standard care.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am an adult aged 18 or older
  • I have been diagnosed with spontaneous intracerebral hemorrhage
  • I have symptoms that started within the last 24 hours

You may not be able to join if

  • I have had previous care limitations
  • I have a serious illness with a short life expectancy
  • My hemorrhage was caused by a brain tumor or blood clot in the brain
  • I have signs of severe brain pressure when I first arrive at the hospital
  • I am pregnant and more than 22 weeks along without medical advice

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
Spontaneous intracerebral haemorrhage (ICH) accounts for approximately 10-15% of all strokes but stands for 50% of stroke-related morbidity and mortality. Approximately half of all patients with ICH have a decreased level of consciousness at hospital admission. Despite this, intensive care and neurosurgical interventions are uncommon. A study conducted in low- and middle-income countries has demon…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adults (age ≥18 years) * Non-contrast computerized tomography (NCCT) imaging-verified diagnosis of spontaneous intracerebral haemorrhage * ≤24 hours from symptom onset or presumed symptom onset (last seen well) Exclusion Criteria: * Previous care limitation * End-stage comor…
Contacts

Teresa Ullberg, MD, PhD

0046175057

i-catcher@med.lu.se

CONTACT

Trine Apostolaki-Hansson, MD PhD

trine.apostolaki-hansson@med.lu.se

CONTACT